NCT04345718 2025-12-09
EXHITENTRE
Hennepin Healthcare Research Institute
Phase 2/3 Completed
Clinical Trials
15 trialsNCT03593187 2025-11-20
GENHIV
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Completed
NCT03984214 2025-04-10
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase 3 Completed
NCT05410535 2024-06-28
To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
Daewoong Pharmaceutical Co. LTD.
Phase 4 Completed
NCT06250075 2024-05-13
PRONIC-G
Universidade Federal do Amazonas
Phase NA Completed
NCT05021263 2024-04-09
Does IV Magnesium Improve Quality of Recovery With ERAS Protocols in Laparoscopic Colorectal Surgery?
Thomas Jefferson University
Phase 3 Completed
NCT03215017 2023-03-09
Effect of Treatment of Low Anterior Resection Syndrome After Rectal Cancer Surgery
Karolinska Institutet
Phase NA Completed
NCT00042341 2022-05-27
Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)
Sanofi
Phase 2 Completed
NCT00913068 2021-10-04
TAP
Nova Scotia Health Authority
Phase NA Completed
NCT01784757 2021-03-17
ARAFOR
Orion Corporation, Orion Pharma
Phase 1 Completed
NCT00042354 2015-03-05
Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients
Sanofi
Phase 2 Completed
NCT00317642 2014-04-14
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
Sanofi
Phase 3 Completed
NCT00044889 2014-03-19
Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia
Sanofi
Phase 2 Completed
NCT00125827 2014-03-19
Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors
Sanofi
Phase 1 Completed
NCT00125840 2014-02-05
Clofarabine in Adult Patients With Advanced Solid Tumors
Sanofi
Phase 1 Completed